» Authors » Loren Herrera Hernandez

Loren Herrera Hernandez

Explore the profile of Loren Herrera Hernandez including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 225
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohan A, Barbir E, Hernandez L, Leung N, Herrmann S
Clin Kidney J . 2025 Feb; 18(2):sfae425. PMID: 39974847
We report a case of acute interstitial nephritis (AIN) in a 68-year-old male with squamous cell carcinoma (SCC) and relapsed/refractory multiple myeloma (RRMM) who developed acute kidney injury (AKI) shortly...
2.
Tekin B, Cubilla A, Cheville J, Smith C, Jenkins S, Dasari S, et al.
Hum Pathol . 2024 Jun; 150:9-19. PMID: 38909709
Objectives: There is a paucity of data on North American cohorts of patients with penile squamous cell carcinoma (pSCC). Herein, we aimed to assess the sensitivity of various modalities to...
3.
Pagliaro L, Tekin B, Gupta S, Hernandez L
Cancers (Basel) . 2024 Jun; 16(11). PMID: 38893204
Discovery of effective systemic therapies for patients with advanced penile cancer has been slow to occur. Comprehensive genomic profiling from several studies shed light on the molecular oncogenesis of penile...
4.
Tekin B, Sali A, Menon S, Cheville J, Smith C, Jenkins S, et al.
Hum Pathol . 2024 May; 148:81-86. PMID: 38782101
The staging for pT2/pT3 penile squamous cell carcinoma (pSCC) has undergone major changes. Some authors proposed criteria wherein the distinction between pT2/pT3 was made using the same histopathological variables that...
5.
Nielson K, Rowsey R, Dasari S, Sukov W, Kipp B, Raghunathan A, et al.
Hum Pathol . 2024 Apr; 146:57-65. PMID: 38615998
Mucinous tubular and spindle cell carcinoma (MTSCC) shows significant overlap with papillary renal cell carcinoma (PRCC), and harbor recurrent copy-number alterations (CNA). We evaluated 16 RCC with features suggestive of...
6.
Dasari S, McCarthy M, Wojcik A, Pitel B, Samaddar A, Tekin B, et al.
Prostate Cancer Prostatic Dis . 2024 Feb; PMID: 38413763
Primary prostatic adenocarcinoma (pPC) undergoes genomic evolution secondary to therapy-related selection pressures as it transitions to metastatic noncastrate (mNC-PC) and castrate resistant (mCR-PC) disease. Next generation sequencing results were evaluated...
7.
Barbour S, Coppo R, Er L, Pillebout E, Russo M, Alpers C, et al.
Clin J Am Soc Nephrol . 2024 Jan; 19(4):438-451. PMID: 38261310
Background: Nephritis is a common manifestation of IgA vasculitis and is morphologically indistinguishable from IgA nephropathy. While MEST-C scores are predictive of kidney outcomes in IgA nephropathy, their value in...
8.
Gilani S, Dasari S, Tekin B, Hernandez L, Cheville J, Jimenez R, et al.
Hum Pathol . 2023 Nov; 142:62-67. PMID: 37979953
Objectives: To determine the prevalence of different amyloid types and frequency of associated systemic amyloidosis in the urinary tract/prostate. Methods: We studied Congo red-positive prostate (n = 150) and urinary...
9.
Tekin B, Cheville J, Hernandez L, Negron V, Smith C, Jenkins S, et al.
Hum Pathol . 2023 Nov; 142:42-50. PMID: 37977513
Objectives: There is an unmet need for therapeutically relevant biomarkers for advanced penile squamous cell carcinoma (pSCC). Proposed immunohistochemistry (IHC)-based biomarkers include programmed death-ligand 1 (PD-L1), trophoblast cell-surface antigen 2...
10.
Afrouzian M, Kozakowski N, Liapis H, Broecker V, Truong L, Avila-Casado C, et al.
Transpl Int . 2023 Nov; 36:12047. PMID: 37908678
[This corrects the article DOI: 10.3389/ti.2023.11590.].